BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11937504)

  • 1. Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha.
    Wärnmark A; Treuter E; Gustafsson JA; Hubbard RE; Brzozowski AM; Pike AC
    J Biol Chem; 2002 Jun; 277(24):21862-8. PubMed ID: 11937504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communication between the ERRalpha homodimer interface and the PGC-1alpha binding surface via the helix 8-9 loop.
    Greschik H; Althage M; Flaig R; Sato Y; Chavant V; Peluso-Iltis C; Choulier L; Cronet P; Rochel N; Schüle R; Strömstedt PE; Moras D
    J Biol Chem; 2008 Jul; 283(29):20220-30. PubMed ID: 18441008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
    Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.
    Kallen J; Schlaeppi JM; Bitsch F; Filipuzzi I; Schilb A; Riou V; Graham A; Strauss A; Geiser M; Fournier B
    J Biol Chem; 2004 Nov; 279(47):49330-7. PubMed ID: 15337744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.
    Shiau AK; Barstad D; Loria PM; Cheng L; Kushner PJ; Agard DA; Greene GL
    Cell; 1998 Dec; 95(7):927-37. PubMed ID: 9875847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.
    Bramlett KS; Wu Y; Burris TP
    Mol Endocrinol; 2001 Jun; 15(6):909-22. PubMed ID: 11376110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coactivator LXXLL nuclear receptor recognition motif.
    Savkur RS; Burris TP
    J Pept Res; 2004 Mar; 63(3):207-12. PubMed ID: 15049832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities.
    Ding XF; Anderson CM; Ma H; Hong H; Uht RM; Kushner PJ; Stallcup MR
    Mol Endocrinol; 1998 Feb; 12(2):302-13. PubMed ID: 9482670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.
    Northrop JP; Nguyen D; Piplani S; Olivan SE; Kwan ST; Go NF; Hart CP; Schatz PJ
    Mol Endocrinol; 2000 May; 14(5):605-22. PubMed ID: 10809226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.
    Dubbink HJ; Hersmus R; Verma CS; van der Korput HA; Berrevoets CA; van Tol J; Ziel-van der Made AC; Brinkmann AO; Pike AC; Trapman J
    Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors.
    Johansson L; Båvner A; Thomsen JS; Färnegårdh M; Gustafsson JA; Treuter E
    Mol Cell Biol; 2000 Feb; 20(4):1124-33. PubMed ID: 10648597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition and accommodation at the androgen receptor coactivator binding interface.
    Hur E; Pfaff SJ; Payne ES; Grøn H; Buehrer BM; Fletterick RJ
    PLoS Biol; 2004 Sep; 2(9):E274. PubMed ID: 15328534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
    Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
    Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro fluorescence anisotropy analysis of the interaction of full-length SRC1a with estrogen receptors alpha and beta supports an active displacement model for coregulator utilization.
    Wang S; Zhang C; Nordeen SK; Shapiro DJ
    J Biol Chem; 2007 Feb; 282(5):2765-75. PubMed ID: 17135255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERalpha and ERbeta.
    Wärnmark A; Almlöf T; Leers J; Gustafsson JA; Treuter E
    J Biol Chem; 2001 Jun; 276(26):23397-404. PubMed ID: 11303023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators. ER selective ligands.
    Wong CW; Komm B; Cheskis BJ
    Biochemistry; 2001 Jun; 40(23):6756-65. PubMed ID: 11389589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
    Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
    J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding.
    Rodriguez AL; Tamrazi A; Collins ML; Katzenellenbogen JA
    J Med Chem; 2004 Jan; 47(3):600-11. PubMed ID: 14736241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.
    Voegel JJ; Heine MJ; Tini M; Vivat V; Chambon P; Gronemeyer H
    EMBO J; 1998 Jan; 17(2):507-19. PubMed ID: 9430642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA.
    Watanabe M; Yanagisawa J; Kitagawa H; Takeyama K; Ogawa S; Arao Y; Suzawa M; Kobayashi Y; Yano T; Yoshikawa H; Masuhiro Y; Kato S
    EMBO J; 2001 Mar; 20(6):1341-52. PubMed ID: 11250900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.